ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Health Technology

Kobayashi Pharmaceutical Co., Ltd.

Business Summary

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.

Financial Highlights

Dec 2021 JPYUSD
Revenue155,252M1,413.01M
Gross Profit86,379M786.16M
Operating income25,846M235.23M
Income before tax27,636M251.52M
Net income19,715M179.43M
EBITDA30,681M279.24M
Diluted EPS252.352.29
Dividends Per Share830.75
Total Assets252,554M2,193.16M
Total liabilities56,952M494.56M
Total equity195,600M1,698.58M
Operating cash flow22,419M204.04M
Currency in JPYCurrency in USD

Historical Data

 Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021
Revenue 156,761M 167,479M 158,340M 150,514M 155,252M
Gross Profit 94,189M 101,963M 89,689M 84,125M 86,379M
Operating income 22,809M 26,191M 25,512M 25,809M 25,846M
Income before tax 22,572M 25,304M 26,804M 26,635M 27,636M
Net income 15,863M 18,023M 19,139M 19,205M 19,715M
EBITDA 26,328M 29,594M 29,639M 29,915M 30,681M
Diluted EPS 201.02 227.95 244.07 245.70 252.35
Dividends Per Share 58 66 73 77 83
Total Assets 218,831M 228,787M 233,732M 238,366M 252,554M
Total liabilities 65,016M 62,536M 61,072M 55,781M 56,952M
Total equity 153,811M 166,249M 172,657M 182,583M 195,600M
Operating cash flow 22,350M 20,007M 20,089M 23,986M 22,419M
 Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021
Revenue 1,397.98M 1,516.43M 1,452.51M 1,409.72M 1,413.01M
Gross Profit 839.97M 923.21M 822.75M 787.91M 786.16M
Operating income 203.40M 237.14M 234.03M 241.72M 235.23M
Income before tax 201.29M 229.11M 245.88M 249.46M 251.52M
Net income 141.46M 163.18M 175.56M 179.87M 179.43M
EBITDA 234.79M 267.95M 271.89M 280.18M 279.24M
Diluted EPS 1.79 2.06 2.23 2.30 2.29
Dividends Per Share 0.51 0.59 0.66 0.72 0.75
Total Assets 1,942.57M 2,085.28M 2,150.74M 2,308.74M 2,193.16M
Total liabilities 577.15M 569.98M 561.96M 540.27M 494.56M
Total equity 1,365.38M 1,515.28M 1,588.74M 1,768.44M 1,698.58M
Operating cash flow 199.31M 181.15M 184.28M 224.65M 204.04M

Valuation Measures

Dec 2021
PER35.82
ROA8.03%
ROE10.42%
Operating margin16.64%
Profit margin12.69%

Key executives

  • President & Representative Director: Akihiro Kobayashi
  • Manager-Finance & Accounting: Noriaki Hirao
  • Executive Officer & General Manager-Manufacturing: Tetsuji Nishioka
  • Executive Officer & Manager-Healthcare Business: Fujito Owaki
  • Executive Officer & Manager-Mail Order Sales: Yoshihiro Ogawa

Shareholders

  • KOBAYASHI AKIHIRO /KOBAYASHI PHARMACEUTICAL/ (11.8%)
  • Kobayashi Foundation (7.6%)
  • WATANABE IKUKO (3.1%)
  • MFS International (UK) Ltd. (3.1%)
  • Ohtori Ltd. (2.7%)
  • MIYATA FAMILY /KOBAYASHI PHARMACEUTICAL/ (2.6%)
  • Kobayashi Pharmaceutical Co., Ltd. (2.6%)
  • Nomura Asset Management Co., Ltd. (2.4%)
  • IUE YUKAKO (2.3%)
  • The Vanguard Group, Inc. (2.0%)

Contact Details

  • Website:http://www.kobayashi.co.jp
  • Address: KDX Kobayashi Doshomachi Building, 4-4-10 Dosho-machi, Osaka, 541-0045, Japan
  • Phone: +81.6.6231.1144

Related Companies

  • Kobayashi Pharmaceutical Global E-Commerce Co. Ltd.
  • Kobayashi Pharmaceutical Value Support Co., Ltd.
  • Kiribai Kobayashi Pharmaceutical Co., Ltd.
  • Kobayashi Pharmaceutical Logistics Co. Ltd.
  • Kobayashi Healthcare International, Inc.
  • Jiangsu Kobayashi Pharmaceutical Co. Ltd.
  • True Nature Co. Ltd.
  • Kobayashi Pharmaceutical Aoitori Foundation
  • Kobayashi America Manufacturing LLC
  • Hefei Kobayashi Daily Chemicals Co. Ltd.
  • PT Kobayashi Pharmaceutical Indonesia
  • Kobayashi Healthcare LLC
  • Kobayashi Healthcare (Malaysia) Sdn. Bhd.
  • Kobayashi Pharmaceutical (Taiwan) Co. Ltd.
  • Kobayashi Healthcare of America, Inc.
  • Shanghai Kobayashi Pharmaceutical Business Co. Ltd.
  • Hefei Kobayashi Daily Products Co. Ltd.
  • Kobayashi Healthcare (Thailand) Co., Ltd.
  • PT Kobayashi Eglin
  • KOBAYASHI Pharmaceutical (Singapore) Pte Ltd.
  • Kobayashi Pharmaceutical (Hong Kong) Co., Ltd.
  • Kobayashi Healthcare Australia Pty Ltd.
  • Kobayashi Healthcare Europe Ltd.
  • Rokuyou-Seiyaku, Inc.
  • Kobayashi Medical America LLC
  • Archer Corp. (Japan)
  • Meitan Hompo Co. Ltd.
  • Kobayashi Pharmaceutical Business Association
  • Ehime Kobayashi Pharmaceutical Co. Ltd.
  • Kobayashi Pharmaceutical Distribution Co. Ltd.

Competitors

    Last Updated on 3 Feb, 2023

    Discover the all new Nikkei Asia app

    • Take your reading anywhere with offline reading functions
    • Never miss a story with breaking news alerts
    • Customize your reading experience

    Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

    Celebrate our next chapter
    Free access for everyone - Sep. 30

    Find out more